AARP “Rx Watchdog” Tracking Price Increases Ahead of Medicare Benefit

An upcoming AARP "Rx Watchdog" study will analyze price increases enacted by manufacturers in the first quarter of 2004 heading into the launch of the Medicare drug discount card program

More from Archive

More from Pink Sheet